Literature DB >> 9399726

Coronary angioplasty induces a systemic inflammatory response.

R R Azar1, R G McKay, F J Kiernan, B Seecharran, Y J Feng, D B Fram, A H Wu, D D Waters.   

Abstract

C-reactive protein (CRP) levels increased more than sixfold above baseline when measured 48 hours after elective percutaneous transluminal coronary angioplasty (PTCA) in patients without underlying inflammatory conditions and did not change significantly in controls undergoing coronary angiography. Only 3 of the 42 PTCA patients had clinical restenosis and underwent target vessel revascularization during the 6-month follow-up, but 2 of the 3 had very high CRP levels 48 hours after the procedure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9399726     DOI: 10.1016/s0002-9149(97)00726-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

1.  Brachial artery low-flow-mediated constriction is increased early after coronary intervention and reduces during recovery after acute coronary syndrome: characterization of a recently described index of vascular function.

Authors:  Jonathan R Spiro; Janet E Digby; Gopal Ghimire; Mark Mason; Andrew G Mitchell; Charles Ilsley; Ann Donald; Miles C D Dalby; Rajesh K Kharbanda
Journal:  Eur Heart J       Date:  2010-10-29       Impact factor: 29.983

2.  Azithromycin does not prevent six-month myointimal proliferation but attenuates the transient systemic inflammation occurring after coronary stenting.

Authors:  Dimas T Ikeoka; Carolina Z Vieira; Pedro A Lemos; Tania V Strabelli; Expedito E Ribeiro da Silva; Marco A Perin; Andrea Groselj-Strele; Beate Tiran; Andreas Tiran; Bruno Caramelli
Journal:  Clin Res Cardiol       Date:  2008-10-13       Impact factor: 5.460

3.  Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention.

Authors:  Nihat Ozer; Burak Tangurek; Fatih Firat; Songul Ozer; Zeynep Tartan; Recep Ozturk; Batuhan Ozay; Figen Ciloglu; Hale Yilmaz; Nese Cam
Journal:  Heart Vessels       Date:  2008-04-04       Impact factor: 2.037

4.  Elevation of the soluble thrombomodulin levels is associated with inflammation after percutaneous coronary interventions.

Authors:  Ting-Hsing Chao; Yi-Heng Li; Wei-Chuan Tsai; Jyh-Hong Chen; Ping-Yen Liu; Liang-Min Tsai
Journal:  Clin Cardiol       Date:  2004-07       Impact factor: 2.882

5.  Increase in interleukin-6 in the first hour after coronary stenting: an early marker of the inflammatory response.

Authors:  Atul Aggarwal; David J Schneider; Edward F Terrien; Kristin E Gilbert; Harold L Dauerman
Journal:  J Thromb Thrombolysis       Date:  2003-02       Impact factor: 2.300

6.  PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin.

Authors:  James T Willerson; Greg Cable; Edward T H Yeh
Journal:  Tex Heart Inst J       Date:  2009

7.  Response of high-sensitivity C-reactive protein to percutaneous coronary intervention in patients with acute coronary syndrome.

Authors:  Kyeong Ho Yun; Myung Ho Jeong; Seok Kyu Oh; Sang Jae Rhee; Eun Mi Park; Eun Mi Lee; Nam Jin Yoo; Nam-Ho Kim; Young Keun Ahn; Jin-Won Jeong
Journal:  Heart Vessels       Date:  2009-05-24       Impact factor: 2.037

8.  Correlations between coronary plaque tissue composition assessed by virtual histology and blood levels of biomarkers for coronary artery disease.

Authors:  Young-Guk Ko; Van Cuong Le; Bo Hyun Kim; Dong-Ho Shin; Jung-Sun Kim; Byeong-Keuk Kim; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Yonsei Med J       Date:  2012-05       Impact factor: 2.759

9.  Immunostimulatory effects of the standardized extract of Tinospora crispa on innate immune responses in Wistar Kyoto rats.

Authors:  Waqas Ahmad; Ibrahim Jantan; Endang Kumolosasi; Syed Nasir Abbas Bukhari
Journal:  Drug Des Devel Ther       Date:  2015-06-10       Impact factor: 4.162

10.  Comparison of immediate and 2-year outcomes between excimer laser-assisted angioplasty with spot stent and primary stenting in intermediate to long femoropopliteal disease.

Authors:  Tien-Yu Wu; Hsin-Hua Chou; Shang-Hung Chang; Yueh-Ju Tsai; Chien-An Hsieh; Shih-Tsung Cheng; Kuan-Hung Yeh; Hern-Jia Chang; Yu-Lin Ko; Hsuan-Li Huang
Journal:  ScientificWorldJournal       Date:  2013-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.